News

Newsletter

New subject codes for filing applications for GMP certification for biological products industries

Last Friday, September 9th, the Brazilian FDA (ANVISA) published and made available new subject codes for submitting requests related to the Good Manufacturing Practices certifications – GMP (“BPF” in Portuguese) for biological products industries.

Formerly, the protocol was carried out under subject codes related to Medicines – Sterile Products. In such scenario, the Brazilian FDA faced difficulties in monitoring the processes, and the procedures were more complex.

According to the Agency, the applicant is not required to make any changes to the petitions that have already been filed, as they will be regularly analyzed by the responsible department.

Find below the list of new subjects that must be used for new requests:

For more news and content related to ANVISA, please do not hesitate to contact us at: regulatorio@kasznarleonardos.com.

Back

Last related news

12 de June de 2026

Ambush Marketing: opportunities, risks and legal boundaries in sporting events

Major events with international reach represent prominent opportunities for publicity and brand strengthening for companies of all sizes. In a period shaped Ambush Marketing: opportunities, risks and legal boundaries in sporting events

Ler notícia

15 de May de 2026

CONAR updates Influencers Guide in line with the new requirements for transparency and protection in the digital environment

The National Council for Advertising Self-Regulation (“CONAR”) released, last Monday (11), the new edition of the Guide to Marketing and Advertising by CONAR updates Influencers Guide in line with the new requirements for transparency and protection in the digital environment

Ler notícia

11 de May de 2026

Digital ECA: Signs of Practical Enforcement of the New Regulatory Framework

The Digital Statute of the Child and Adolescent (Law No. 15,211/2025 – “Digital ECA”) came into effect in March 2026 and is Digital ECA: Signs of Practical Enforcement of the New Regulatory Framework

Ler notícia